日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Society for Immunotherapy of Cancer: Standards for Reporting of Multiplex Immunohistochemistry/Immunofluorescence Assays (STORMI).

癌症免疫治疗学会:多重免疫组织化学/免疫荧光检测报告标准(STORMI)。

Sater Sam, Bifulco Carlo B, Rodriguez-Canales Jaime, Yeong Joe, Akturk Guray, Angelo Michael, Ballesteros-Merino Carmen, Bankhead Peter, Basu Subham, Blando Jorge M, Brajkovic Saska, Cassano Marco, Chen Benjamin J, Coskun Ahmet F, Cottrell Tricia R, De Andrea Carlos E, Edwards Robin H, Egelston Colt, Engle Logan L, Ernstoff Marc S, Fan Rong, Feldman Michael, Fox Bernard A, Galon Jerome, Gartrell Robyn, Gnjatic Sacha, Green Benjamin F, Gulley James L MD, Hellebust Anne, Hewitt Stephen, Hollmann Travis J, Horn Lucas A, Howat William J, Hoyt Clifford C, Jensen Shawn M, Kulasinghe Arutha, Lassoued Wiem, Lott Steven, Mansfield James, Marwitz Sebastian, Netto George, Page David B, Parra Edwin, Rimm David L, Rodig Scott J, Salgado Roberto, Schapiro Denis, Schalper Kurt A MD, Sunshine Joel C, Surace Michael J, Szalay Alexander S, Thurin Magdalena, Villasboas Jose C, Wharton Keith, Wistuba Ignacio I, Yearley Jennifer H, Yuan Yinyin, Zaki Geroge, Ziai James, Taube Janis M

INTERLINK-1: A Phase III, Randomized, Placebo-Controlled Study of Monalizumab plus Cetuximab in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

INTERLINK-1:一项评估莫那珠单抗联合西妥昔单抗治疗复发/转移性头颈部鳞状细胞癌的III期随机、安慰剂对照研究

Fayette, Jérôme; Licitra, Lisa; Harrington, Kevin; Haddad, Robert; Siu, Lillian L; Liu, Yi-Chun; Tahara, Makoto; Machiels, Jean-Pascal; Rischin, Danny; Seiwert, Tanguy Y; Ferris, Robert L; Keilholz, Ulrich; Psyrri, Amanda; Keam, Bhumsuk; Bossi, Paolo; Metcalf, Robert; Hsieh, Ching-Yun; Clement, Paul M J; Isaev, Pavel; Mudunov, Ali; Dinis, José; Hoeben, Ann; Kasper, Stefan; Klinghammer, Konrad; Hwang, Michael; Blando, Jorge; Serrano, Olivier; Ruscica, Dario; Cohen, Roger B

Exploring the impact of tertiary lymphoid structures maturity in NSCLC: insights from TLS scoring

探讨三级淋巴结构成熟度对非小细胞肺癌的影响:来自TLS评分的启示

Berthe, Julie; Poudel, Pawan; Segerer, Felix J; Jennings, Emily C; Ng, Felicia; Surace, Michael; Andoni, Alma; Testori, Marco; Saraiya, Megha; Vuko, Miljenka; Hessel, Harald; Heininen-Brown, Mari; Blando, Jorge; Jones, Emma V; Willis, Sophie E; Galon, Jérôme; van de Ven, Rieneke; de Gruijl, Tanja D; Angell, Helen K

Neoadjuvant Durvalumab Alone or Combined with Novel Immuno-Oncology Agents in Resectable Lung Cancer: The Phase II NeoCOAST Platform Trial

新辅助度伐利尤单抗单药或联合新型免疫肿瘤药物治疗可切除肺癌:II期NeoCOAST平台试验

Cascone, Tina; Kar, Gozde; Spicer, Jonathan D; García-Campelo, Rosario; Weder, Walter; Daniel, Davey B; Spigel, David R; Hussein, Maen; Mazieres, Julien; Oliveira, Julio; Yau, Edwin H; Spira, Alexander I; Anagnostou, Valsamo; Mager, Raymond; Hamid, Oday; Cheng, Lin-Yang; Zheng, Ying; Blando, Jorge; Tan, Tze Heng; Surace, Michael; Rodriguez-Canales, Jaime; Gopalakrishnan, Vancheswaran; Sellman, Bret R; Grenga, Italia; Soo-Hoo, Yee; Kumar, Rakesh; McGrath, Lara; Forde, Patrick M

A Randomized Phase II Study of MEDI0680 in Combination with Durvalumab versus Nivolumab Monotherapy in Patients with Advanced or Metastatic Clear-cell Renal Cell Carcinoma

一项随机II期研究,比较MEDI0680联合度伐利尤单抗与纳武利尤单抗单药治疗晚期或转移性透明细胞肾细胞癌患者的疗效

Voss, Martin H; Azad, Arun A; Hansen, Aaron R; Gray, Jhanelle E; Welsh, Sarah J; Song, Xuyang; Kuziora, Michael; Meinecke, Lina; Blando, Jorge; Achour, Ikbel; Wang, Yi; Walcott, Farzana L; Oosting, Sjoukje F

Phase 1b study of pegylated arginine deiminase (ADI-PEG 20) plus Pembrolizumab in advanced solid cancers

聚乙二醇化精氨酸脱亚胺酶(ADI-PEG 20)联合帕博利珠单抗治疗晚期实体瘤的1b期研究

Chang, Kwang-Yu; Chiang, Nai-Jung; Wu, Shang-Yin; Yen, Chia-Jui; Chen, Shang-Hung; Yeh, Yu-Min; Li, Chien-Feng; Feng, Xiaoxing; Wu, Katherine; Johnston, Amanda; Bomalaski, John S; Wu, Bor-Wen; Gao, Jianjun; Subudhi, Sumit K; Kaseb, Ahmed O; Blando, Jorge M; Yadav, Shalini S; Szlosarek, Peter W; Chen, Li-Tzong

Immune profiling of human tumors identifies CD73 as a combinatorial target in glioblastoma

人类肿瘤免疫谱分析发现 CD73 是胶质母细胞瘤的联合治疗靶点

Goswami, Sangeeta; Walle, Thomas; Cornish, Andrew E; Basu, Sreyashi; Anandhan, Swetha; Fernandez, Irina; Vence, Luis; Blando, Jorge; Zhao, Hao; Yadav, Shalini Singh; Ott, Martina; Kong, Ling Y; Heimberger, Amy B; de Groot, John; Sepesi, Boris; Overman, Michael; Kopetz, Scott; Allison, James P; Pe'er, Dana; Sharma, Padmanee

Efficacy, Safety, and Biomarkers of Response to Azacitidine and Nivolumab in Relapsed/Refractory Acute Myeloid Leukemia: A Nonrandomized, Open-Label, Phase II Study

阿扎胞苷联合纳武利尤单抗治疗复发/难治性急性髓系白血病的疗效、安全性及反应生物标志物:一项非随机、开放标签的II期研究

Daver, Naval; Garcia-Manero, Guillermo; Basu, Sreyashi; Boddu, Prajwal C; Alfayez, Mansour; Cortes, Jorge E; Konopleva, Marina; Ravandi-Kashani, Farhad; Jabbour, Elias; Kadia, Tapan; Nogueras-Gonzalez, Graciela M; Ning, Jing; Pemmaraju, Naveen; DiNardo, Courtney D; Andreeff, Michael; Pierce, Sherry A; Gordon, Tauna; Kornblau, Steven M; Flores, Wilmer; Alhamal, Zainab; Bueso-Ramos, Carlos; Jorgensen, Jeffrey L; Patel, Keyur P; Blando, Jorge; Allison, James P; Sharma, Padmanee; Kantarjian, Hagop

High OX-40 expression in the tumor immune infiltrate is a favorable prognostic factor of overall survival in non-small cell lung cancer

肿瘤免疫浸润中OX-40高表达是无小细胞肺癌患者总体生存的有利预后因素

Massarelli, Erminia; Lam, Vincent K; Parra, Edwin R; Rodriguez-Canales, Jaime; Behrens, Carmen; Diao, Lixia; Wang, Jing; Blando, Jorge; Byers, Lauren A; Yanamandra, Niranjan; Brett, Sara; Morley, Peter; Sharma, Padmanee; Allison, James; Wistuba, Ignacio I; Heymach, John V

Anti-CTLA-4 Immunotherapy Does Not Deplete FOXP3+ Regulatory T Cells (Tregs) in Human Cancers

抗 CTLA-4 免疫疗法不会消耗人类癌症中的 FOXP3+ 调节性 T 细胞 (Treg)

Anu Sharma #, Sumit K Subudhi #, Jorge Blando, Jorge Scutti, Luis Vence, Jennifer Wargo, James P Allison, Antoni Ribas, Padmanee Sharma